Thus, complex network involving tumoral and stromal (immune) CXCL13 and CXCR5 integrate to promote cancer cell autonomous and non-autonomous responses, highlighting autocrine, paracrine and endocrine interactions in dictating aggressive cancer phenotypes. The gene discussed is CXCL13; the disease is cancer.